NPHC Stock Analysis

Nutra Pharma Corp - Real-time stock metrics, market data, and comprehensive analysis

Loading...

Fetching stock data...

Nutra Pharma Corp

Nutra Pharma Corp. is a biopharmaceutical company engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. The Company's products are Cobroxin and Nyloxin/Nyloxin Extra Strength. The wholly owned subsidiaries of the Company are ReceptoPharm, Inc. (ReceptoPharm) and Designer Diagnostics, Inc. (Designer Diagnostics).

Market Data

Current Price

$0.00

+$0.00 (0.00%)
Market Cap

-

Total Company Value
Day Range
$0.00 - $0.00
Session Volume
-
Last session total

Valuation Metrics

P/E Ratio

-

Price ÷ Earnings
EPS (Basic)

-

Earnings Per Share
Price-to-Book

-

Market Value ÷ Book Value

Financial Health

Revenue (TTM)

-

Trailing 12 Months
Net Income (TTM)

-

Profit After Tax
Gross Margin

-

Revenue Efficiency

Returns & Dividends

Dividend Yield

-

Annual Dividend ÷ Price
Annual Dividend

-

Per Share
Payout Ratio

-

Dividend ÷ EPS

Price Performance

Price Chart
All times are in Eastern Time (ET)

Recent News

No news available

Data Source: Financial data is sourced from SEC filings via Tiingo and may be delayed. Market Status: CLOSED - Showing latest available data. (Last updated: 3:23 PM)
Logos provided by Logo.dev

Contact Me

Have a question or want to work together? Fill out the form below and we’ll get back to you as soon as possible.

Contact Form Demo

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.